Similar articles

• Construction of expression vectors for the production of interferons in yeast.

  Devenish RJ, Maxwell RJ, Beilharz MW, Nagley P, Linnane AW. Devenish RJ, et al. Dev Biol Stand. 1987;67:185-99. Dev Biol Stand. 1987. PMID: 2440740
• Purification and characterization of recombinant proteins. Opportunities and challenges.

  Heinrikson RL, Tomasselli AG. Heinrikson RL, et al. Bioprocess Technol. 1991;12:3-28. Bioprocess Technol. 1991. PMID: 1370029 Review. No abstract available.
• Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus.

  Schultz U, Köck J, Schlicht HJ, Staeheli P. Schultz U, et al. Virology. 1995 Oct 1;212(2):641-9. doi: 10.1006/viro.1995.1522. Virology. 1995. PMID: 7571434
• The purification and manufacture of human interferons. Their promise is still not fulfilled, but now their genes have been isolated and cloned in E. coli. The bacteria are making interferon in quantity and the bacterial product is undergoing clinical trials.

  Pestka S. Pestka S. Sci Am. 1983 Aug;249(2):37-43. Sci Am. 1983. PMID: 6194559 No abstract available.
• The human interferons: from the past and into the future.

  Pestka S, Langer JA, Fisher PB, Weinstein IB, Ortaldo J, Herberman RB. Pestka S, et al. Symp Fundam Cancer Res. 1984;37:261-81. Symp Fundam Cancer Res. 1984. PMID: 6084862 Review. No abstract available.